Alice Marie Stek, MD

Title(s)Assistant Professor of Clinical Obstetrics & Gynecology
AddressIRD 220 2020 Zonal Ave
Off Campus
Los Angeles CA 90033
Phone+1 323 226 2534
vCardDownload vCard
    Other Positions
    Title(s)Director, HIV Services


    Collapse Overview 
    Collapse Overview
    Dr. Stek completed a residency in Obstetrics and Gynecology and a fellowship in maternal-fetal medicine (MFM). Her research and clinical interests are primarily in the field of HIV in pregnancy and HIV in women. She has been conducting clinical research in these areas since starting her MFM Fellowship. Dr. Stek has been active in the Pediatric AIDS Clinical Trials Group for over 12 years, where she serves on the Perinatal RAC, the Obstetrics Subcommittee and the AACTG Womens Health Committee. She is a member of eight PACTG and AACTG protocol teams and is co-chair and vice-chair of several protocols. She is also a member of the local WIHS team.

    Dr. Steks current research, both in the multicenter research organizations and in the MCA Centers own projects, focuses on the use of antiretroviral medications in pregnancy. Dr. Stek, in collaboration with PACTG pharmacologists in Boston, San Diego, and San Francisco, and locally with Dr. Michael Neely and the USC School of Pharmacy, is studying the pharmacokinetics, and safety and efficacy (collaborating with PACTG, AACTG, and MCA internists and pediatricians) of the medications used to prevent perinatal HIV transmission and for maternal health. Together with a pathologist at Baylor University, she is studying placental pathology in women using antiretrovirals during pregnancy. She collaborated with the USC pathology/lo aboratory medicine department and MCA pediatricians in designing and implementing a rapid HIV testing program for women in labor, and is currently evaluating this program with the USC pathology/laboratory medicine department and an MCA epidemiologist. Other collaborative research projects in the PACTG and AACTG include a comprehensive project to collect data on HIV-infected pregnancies, an evaluation of postpartum virologic and immunologic changes, and a trial of a therapeutic HPV vaccine in HIV-positive adolescents. In addition to these research activities, Dr. Stek provides clinical care for MCAs pregnant patients, and teaches at Womens and Childrens Hospital, USC Keck School of Medicine, and occasionally at USC main campus, as well as outside the university both in the local community and outside of Los Angeles.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lopinavir and tenofovir interaction observed in non-pregnant adults altered during pregnancy. J Clin Pharm Ther. 2021 Jul 12. Mulligan N, Salama E, Momper JD, Capparelli EV, Stek A, Chakhtoura N, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team . PMID: 34254323.
      View in: PubMed   Mentions:    Fields:    
    2. Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV. AIDS. 2021 07 01; 35(8):1191-1199. Momper JD, Wang J, Stek A, Shapiro DE, Scott GB, Paul ME, Febo IL, Burchett S, Smith E, Chakhtoura N, Denson K, Rungruengthanakit K, George K, Yang DZ, Capparelli EV, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team . PMID: 34076612.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    3. Profile of Chronic Comorbid Conditions and Obstetrical Complications among Pregnant Women with HIV and Receiving Antiretroviral Therapy in the United States. Clin Infect Dis. 2021 Mar 26. Venkatesh KK, Morrison L, Tuomala RE, Stek A, Read JS, Shapiro DE, Livingston EG. PMID: 33768226.
      View in: PubMed   Mentions:    Fields:    
    4. Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV. AIDS. 2021 03 01; 35(3):407-417. Brooks KM, Momper JD, Pinilla M, Stek AM, Barr E, Weinberg A, Deville JG, Febo IL, Cielo M, George K, Denson K, Rungruengthanakit K, Shapiro DE, Smith E, Chakhtoura N, Rooney JF, Haubrich R, Espina R, Capparelli EV, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team . PMID: 33252495.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate. Antimicrob Agents Chemother. 2021 02 17; 65(3). Eke AC, Shoji K, Best BM, Momper JD, Stek AM, Cressey TR, Mirochnick M, Capparelli EV. PMID: 33318014.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Darunavir Pharmacokinetics With an Increased Dose During Pregnancy. J Acquir Immune Defic Syndr. 2020 04 01; 83(4):373-380. Eke AC, Stek AM, Wang J, Kreitchmann R, Shapiro DE, Smith E, Chakhtoura N, Capparelli EV, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team . PMID: 31923087.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    7. Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy. Antimicrob Agents Chemother. 2020 03 24; 64(4). Eke AC, Wang J, Amin K, Shapiro DE, Stek A, Smith E, Chakhtoura N, Basar M, George K, Knapp KM, João EC, Rungruengthanakit K, Capparelli E, Burchett S, Mirochnick M, Best BM, P1026s Protocol Team . PMID: 32015036.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    8. Low maternal vitamin D is associated with increased risk of congenital and peri/postnatal transmission of Cytomegalovirus in women with HIV. PLoS One. 2020; 15(2):e0228900. Bearden A, Van Winden K, Frederick T, Kono N, Operskalski E, Pandian R, Barton L, Stek A, Kovacs A. PMID: 32053638.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    9. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2020 01 01; 83(1):72-80. Hoffman RM, Warshaw MG, Amico KR, Pilotto J, Masheto G, Achalapong J, Machado E, Chokephaibulkit K, Duarte G, João E, Graham KK, Knapp KM, Stek AM, Scott GB, Coletti A, Loftis AJ, Chakhtoura N, Currier JS, PROMISE 1077HS Team . PMID: 31651545.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Low Bioactive Vitamin D Is Associated with Pregnancy-Induced Hypertension in a Cohort of Pregnant HIV-Infected Women Sampled Over a 23-Year Period. Am J Perinatol. 2020 12; 37(14):1446-1454. Van Winden KR, Bearden A, Kono N, Frederick T, Operskalski E, Stek A, Pandian R, Barton L, Kovacs A. PMID: 31365935.
      View in: PubMed   Mentions: 2     Fields:    
    11. Efavirenz pharmacokinetics during pregnancy and infant washout. Antivir Ther. 2019; 24(2):95-103. Kreitchmann R, Schalkwijk S, Best B, Wang J, Colbers A, Stek A, Shapiro D, Cressey T, Mirochnick M, Burger D. PMID: 30530925.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV. AIDS. 2018 11 13; 32(17):2507-2516. Momper JD, Best BM, Wang J, Capparelli EV, Stek A, Barr E, Badell ML, Acosta EP, Purswani M, Smith E, Chakhtoura N, Park K, Burchett S, Shapiro DE, Mirochnick M, IMPAACT P1026s Protocol Team . PMID: 30134297.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    13. Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum. J Clin Pharmacol. 2019 03; 59(3):386-393. Eke AC, McCormack SA, Best BM, Stek AM, Wang J, Kreitchmann R, Shapiro D, Smith E, Mofenson LM, Capparelli EV, Mirochnick M, IMPAACT P1026s Protocol Team . PMID: 30358179.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    14. Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum. . 2018 07 01; 78(3):308-313. Eke AC, Chakhtoura N, Kashuba A, Best BM, Sykes C, Wang J, Stek AM, Smith E, Calabrese S, Capparelli EV, Mirochnick M, IMPAACT P1026s Protocol Team . PMID: 29528944.
      View in: PubMed   Mentions:
    15. Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States. Obstet Gynecol. 2018 05; 131(5):879-890. Venkatesh KK, Morrison L, Livingston EG, Stek A, Read JS, Shapiro DE, Tuomala RE. PMID: 29630021.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV. AIDS. 2018 03 27; 32(6):729-737. Mulligan N, Best BM, Wang J, Capparelli EV, Stek A, Barr E, Buschur SL, Acosta EP, Smith E, Chakhtoura N, Burchett S, Mirochnick M, IMPAACT P1026s Protocol Team . PMID: 29369162.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    17. Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus. Obstet Gynecol. 2017 04; 129(4):621-628. Scott GB, Brogly SB, Muenz D, Stek AM, Read JS, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025 Study Team . PMID: 28277349.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    18. Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025. . 2016 09 01; 73(1):74-82. Livingston EG, Huo Y, Patel K, Tuomala RE, Scott GB, Stek A, P1025 Team of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group . PMID: 27082506.
      View in: PubMed   Mentions:
    19. Etravirine Pharmacokinetics in HIV-Infected Pregnant Women. Front Pharmacol. 2016; 7:239. Mulligan N, Schalkwijk S, Best BM, Colbers A, Wang J, Capparelli EV, Moltó J, Stek AM, Taylor G, Smith E, Hidalgo Tenorio C, Chakhtoura N, van Kasteren M, Fletcher CV, Mirochnick M, Burger D. PMID: 27540363.
      View in: PubMed   Mentions:
    20. Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women. . 2016 07 01; 72(3):289-96. Tran AH, Best BM, Stek A, Wang J, Capparelli EV, Burchett SK, Kreitchmann R, Rungruengthanakit K, George K, Cressey TR, Chakhtoura N, Smith E, Shapiro DE, Mirochnick M, IMPAACT P1026s Protocol Team . PMID: 26918544.
      View in: PubMed   Mentions:
    21. Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women. . 2015 Sep 01; 70(1):33-41. Stek A, Best BM, Wang J, Capparelli EV, Burchett SK, Kreitchmann R, Rungruengthanakit K, Cressey TR, Mofenson LM, Smith E, Shapiro D, Mirochnick M. PMID: 25950206.
      View in: PubMed   Mentions:
    22. Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women. Clin Infect Dis. 2015 Nov 15; 61(10):1582-9. Colbers A, Best B, Schalkwijk S, Wang J, Stek A, Hidalgo Tenorio C, Hawkins D, Taylor G, Kreitchmann R, Burchett S, Haberl A, Kabeya K, van Kasteren M, Smith E, Capparelli E, Burger D, Mirochnick M, PANNA Network and the IMPAACT 1026 Study Team . PMID: 26202768.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    23. PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150. Jacobs J AIDS HIV. 2015; 1(1). Sha BE, Tierney C, Sun X, Stek A, Cohn SE, Coombs RW, Bastow B, Aweeka FT, AIDS Clinical Trials Group (ACTG) 5153s Team . PMID: 26878071.
      View in: PubMed   Mentions:
    24. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study. Ann Intern Med. 2015 Jan 20; 162(2):90-9. Katz IT, Leister E, Kacanek D, Hughes MD, Bardeguez A, Livingston E, Stek A, Shapiro DE, Tuomala R. PMID: 25599347.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    25. Raltegravir pharmacokinetics during pregnancy. . 2014 Dec 01; 67(4):375-81. Watts DH, Stek A, Best BM, Wang J, Capparelli EV, Cressey TR, Aweeka F, Lizak P, Kreitchmann R, Burchett SK, Shapiro DE, Hawkins E, Smith E, Mirochnick M, IMPAACT 1026s study team . PMID: 25162818.
      View in: PubMed   Mentions:
    26. The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception. Eur J Contracept Reprod Health Care. 2015 Apr; 20(2):149-53. Atrio J, Stek A, Vora H, Sanchez-Keeland L, Zannat F, Natavio M. PMID: 25285572.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    27. Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy. J Antimicrob Chemother. 2015 Jan; 70(1):217-24. Cressey TR, Urien S, Capparelli EV, Best BM, Buranabanjasatean S, Limtrakul A, Rawangban B, Sabsanong P, Treluyer JM, Jourdain G, Stek A, Lallemant M, Mirochnick M. PMID: 25261418.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    28. Reduced indinavir exposure during pregnancy. Br J Clin Pharmacol. 2013 Sep; 76(3):475-83. Cressey TR, Best BM, Achalapong J, Stek A, Wang J, Chotivanich N, Yuthavisuthi P, Suriyachai P, Prommas S, Shapiro DE, Watts DH, Smith E, Capparelli E, Kreitchmann R, Mirochnick M, IMPAACT P1026s team . PMID: 23305215.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    29. Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy. . 2013 May 01; 63(1):59-66. Kreitchmann R, Best BM, Wang J, Stek A, Caparelli E, Watts DH, Smith E, Shapiro DE, Rossi S, Burchett SK, Hawkins E, Byroads M, Cressey TR, Mirochnick M. PMID: 23392467.
      View in: PubMed   Mentions:
    30. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants. Clin Infect Dis. 2012 Sep; 55(6):877-84. Frederick T, Homans J, Spencer L, Kramer F, Stek A, Operskalski E, Kovacs A. PMID: 22675157.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    31. Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum. . 2012 Mar 01; 59(3):245-52. Cressey TR, Stek A, Capparelli E, Bowonwatanuwong C, Prommas S, Sirivatanapa P, Yuthavisuthi P, Neungton C, Huo Y, Smith E, Best BM, Mirochnick M, IMPAACT P1026s Team . PMID: 22083071.
      View in: PubMed   Mentions:
    32. Effect of pregnancy on emtricitabine pharmacokinetics. HIV Med. 2012 Apr; 13(4):226-35. Stek AM, Best BM, Luo W, Capparelli E, Burchett S, Hu C, Li H, Read JS, Jennings A, Barr E, Smith E, Rossi SS, Mirochnick M. PMID: 22129166.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    33. Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: a cross-sectional study. BMC Infect Dis. 2011 Sep 30; 11:263. Walter J, Fraga L, Orin MJ, Decker WD, Gipps T, Stek A, Aldrovandi GM. PMID: 21961998.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    34. Atazanavir pharmacokinetics with and without tenofovir during pregnancy. . 2011 Apr 15; 56(5):412-9. Mirochnick M, Best BM, Stek AM, Capparelli EV, Hu C, Burchett SK, Rossi SS, Hawkins E, Basar M, Smith E, Read JS, IMPAACT 1026s Study Team . PMID: 21283017.
      View in: PubMed   Mentions:
    35. Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clin Trials. 2011 Jan-Feb; 12(1):9-23. Sha BE, Tierney C, Cohn SE, Sun X, Coombs RW, Frenkel LM, Kalams SA, Aweeka FT, Bastow B, Bardeguez A, Kmack A, Stek A, Aids Clinical Trials Group ACTG A5150 Team . PMID: 21388937.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    36. Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected women. Obstet Gynecol. 2010 Aug; 116(2 Pt 1):335-343. Livingston EG, Huo Y, Patel K, Brogly SB, Tuomala R, Scott GB, Bardeguez A, Stek A, Read JS, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) Protocol 1025 Study . PMID: 20664394.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    37. Lopinavir tablet pharmacokinetics with an increased dose during pregnancy. . 2010 Aug; 54(4):381-8. Best BM, Stek AM, Mirochnick M, Hu C, Li H, Burchett SK, Rossi SS, Smith E, Read JS, Capparelli EV, International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1026s Study Team . PMID: 20632458.
      View in: PubMed   Mentions:
    38. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis. 2010 Apr 01; 201(7):1035-44. Patel K, Shapiro DE, Brogly SB, Livingston EG, Stek AM, Bardeguez AD, Tuomala RE, P1025 team of the International Maternal Pediatric Adolescent AIDS Clinical Trials Group . PMID: 20196654.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    39. Antiretroviral medications during pregnancy for therapy or prophylaxis. Curr HIV/AIDS Rep. 2009 May; 6(2):68-76. Stek AM. PMID: 19358777.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    40. Correlates of perinatal depression in HIV-infected women. AIDS Patient Care STDS. 2009 Feb; 23(2):101-8. Kapetanovic S, Christensen S, Karim R, Lin F, Mack WJ, Operskalski E, Frederick T, Spencer L, Stek A, Kramer F, Kovacs A. PMID: 19196032.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    41. Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serum. HIV Clin Trials. 2009 Jan-Feb; 10(1):41-7. Bennetto-Hood C, Bryson YJ, Stek A, King JR, Mirochnick M, Acosta EP. PMID: 19362995.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    42. Lopinavir exposure with an increased dose during pregnancy. . 2008 Dec 15; 49(5):485-91. Mirochnick M, Best BM, Stek AM, Capparelli E, Hu C, Burchett SK, Holland DT, Smith E, Gaddipati S, Read JS, PACTG 1026s Study Team . PMID: 18989231.
      View in: PubMed   Mentions:
    43. Adherence to antiretrovirals among US women during and after pregnancy. . 2008 Aug 01; 48(4):408-17. Bardeguez AD, Lindsey JC, Shannon M, Tuomala RE, Cohn SE, Smith E, Stek A, Buschur S, Cotter A, Bettica L, Read JS, PACTG 1025 Protocol Team . PMID: 18614923.
      View in: PubMed   Mentions:
    44. Antiretroviral treatment in pregnancy. Curr Opin HIV AIDS. 2008 Mar; 3(2):155-60. Stek AM. PMID: 19372959.
      View in: PubMed   Mentions: 3     Fields:    
    45. Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093. Contraception. 2008 Feb; 77(2):84-90. Watts DH, Park JG, Cohn SE, Yu S, Hitti J, Stek A, Clax PA, Muderspach L, Lertora JJ. PMID: 18226670.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    46. Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the diagnosis of vaginitis. J Low Genit Tract Dis. 2007 Oct; 11(4):240-50. Sha BE, Gawel SH, Hershow RC, Passaro D, Augenbraun M, Darragh TM, Stek A, Golub ET, Mph LC, Moxley MD, Weber KM, Watts DH. PMID: 17917568.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084. Am J Obstet Gynecol. 2007 Apr; 196(4):331.e1-7. Hitti J, Andersen J, McComsey G, Liu T, Melvin A, Smith L, Stek A, Aberg J, Hull A, Alston-Smith B, Watts DH, Livingston E, AIDS Clinical Trials Group 5084 Study Team . PMID: 17403409.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    48. Participation of HIV-infected pregnant women in research in the United States. AIDS Res Hum Retroviruses. 2007 Jan; 23(1):51-3. Brogly S, Read JS, Shapiro D, Stek A, Tuomala R. PMID: 17263632.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    49. Reduced lopinavir exposure during pregnancy. AIDS. 2006 Oct 03; 20(15):1931-9. Stek AM, Mirochnick M, Capparelli E, Best BM, Hu C, Burchett SK, Elgie C, Holland DT, Smith E, Tuomala R, Cotter A, Read JS. PMID: 16988514.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCellsCTClinical Trials
    50. Impact of pregnancy on abacavir pharmacokinetics. AIDS. 2006 Feb 28; 20(4):553-60. Best BM, Mirochnick M, Capparelli EV, Stek A, Burchett SK, Holland DT, Read JS, Smith E, Hu C, Spector SA, Connor JD, PACTG P1026s Study Team . PMID: 16470119.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    51. Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life. . 2005 Jun 01; 39(2):189-94. Mirochnick M, Stek A, Acevedo M, Keller M, Holland D, Capparelli E, Connor J, Huang S, Hughes M, Watts H, Mofenson L, Bryson Y. PMID: 15905735.
      View in: PubMed   Mentions:
    52. HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women. Addiction. 2005 May; 100(5):626-35. Nikolopoulou GB, Nowicki MJ, Du W, Homans J, Stek A, Kramer F, Kovacs A. PMID: 15847620.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    53. Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J Neurol Sci. 2004 Sep 15; 224(1-2):69-76. Gilmore W, Arias M, Stroud N, Stek A, McCarthy KA, Correale J. PMID: 15450773.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    54. Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022. . 2004 Jul 01; 36(3):772-6. Hitti J, Frenkel LM, Stek AM, Nachman SA, Baker D, Gonzalez-Garcia A, Provisor A, Thorpe EM, Paul ME, Foca M, Gandia J, Huang S, Wei LJ, Stevens LM, Watts DH, McNamara J, PACTG 1022 Study Team . PMID: 15213559.
      View in: PubMed   Mentions:
    55. Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother. 2004 Feb; 48(2):430-6. Acosta EP, Bardeguez A, Zorrilla CD, Van Dyke R, Hughes MD, Huang S, Pompeo L, Stek AM, Pitt J, Watts DH, Smith E, Jiménez E, Mofenson L, Pediatric AIDS Clinical Trials Group 386 Protocol Team, . PMID: 14742191.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    56. Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS. 2004 Jan 23; 18(2):281-6. Massad LS, Springer G, Jacobson L, Watts H, Anastos K, Korn A, Cejtin H, Stek A, Young M, Schmidt J, Minkoff H. PMID: 15075546.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    57. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med. 2002 Jun 13; 346(24):1863-70. Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M. PMID: 12063370.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCTClinical Trials